{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:03:47Z","timestamp":1783181027910,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.4158\/ep.14.2.193","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:07:48Z","timestamp":1365199668000},"page":"193-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Premicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker"],"prefix":"10.1016","volume":"14","author":[{"given":"Arti A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Bloomgarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.2.193_bb0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome [published correction appears in N Engl J Med. 1995;333:1435]","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.14.2.193_bb0010","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes."},{"key":"10.4158\/EP.14.2.193_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.4158\/EP.14.2.193_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.14.2.193_bb0030","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0035","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.4158\/EP.14.2.193_bb0040","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study [published correction appears in J Clin Endocrinol Metab. 2004;89:5621]","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00284458","article-title":"Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study","volume":"25","author":"Andersen","year":"1983","journal-title":"Diabetologia."},{"key":"10.4158\/EP.14.2.193_bb0050","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.19.8.1992","article-title":"Urinary albumin excretion: an independent predictor of ischemic heart disease","volume":"19","author":"Borch-Johnsen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.4158\/EP.14.2.193_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1191\/1358863x02vm412ra","article-title":"Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease","volume":"7","author":"Garg","year":"2002","journal-title":"Vasc Med."},{"key":"10.4158\/EP.14.2.193_bb0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.mnh.0000247496.54882.3f","article-title":"Update on microalbuminuria as a biomarker in renal and cardiovascular disease","volume":"15","author":"Lambers Heerspink","year":"2006","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.4158\/EP.14.2.193_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA."},{"key":"10.4158\/EP.14.2.193_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","article-title":"Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes","volume":"110","author":"Klausen","year":"2004","journal-title":"Circulation."},{"key":"10.4158\/EP.14.2.193_bb0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","article-title":"Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study","volume":"112","author":"Arnl\u00f6v","year":"2005","journal-title":"Circulation."},{"key":"10.4158\/EP.14.2.193_bb0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.jhh.1001266","article-title":"Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994\/95","volume":"15","author":"Liese","year":"2001","journal-title":"J Hum Hypertens."},{"key":"10.4158\/EP.14.2.193_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.14.2.193_bb0090","doi-asserted-by":"crossref","first-page":"C85","DOI":"10.1159\/000093995","article-title":"The relationship of microalbuminuria with metabolic syndrome","volume":"104","author":"Choi","year":"2006","journal-title":"Nephron Clin Pract."},{"key":"10.4158\/EP.14.2.193_bb0095","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","article-title":"Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion","volume":"55","author":"Parvanova","year":"2006","journal-title":"Diabetes."},{"key":"10.4158\/EP.14.2.193_bb0100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism."},{"key":"10.4158\/EP.14.2.193_bb0105","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol."},{"key":"10.4158\/EP.14.2.193_bb0115","series-title":"Polycystic Ovary Syndrome: Current Issues in Endocrinology and Metabolism","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: toward a rational approach","author":"Zawadski","year":"1992"},{"key":"10.4158\/EP.14.2.193_bb0120","series-title":"WHO Obesity Technical Report Series","article-title":"Obesity: Preventing and Managing the Global Epidemic","volume":"894","author":"World Health Organization","year":"2000"},{"key":"10.4158\/EP.14.2.193_bb0125","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2001","journal-title":"JAMA."},{"key":"10.4158\/EP.14.2.193_bb0130","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.14.2.193_bb0135","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/archinte.158.17.1933","article-title":"Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study","volume":"158","author":"Cirillo","year":"1998","journal-title":"Arch Intern Med."},{"issue":"Suppl 4","key":"10.4158\/EP.14.2.193_bb0140","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/sj.ijo.0802213","article-title":"Obesity and target organ damage: the kidney","volume":"26","author":"de Jong PE","year":"2002","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.4158\/EP.14.2.193_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.ajkd.2004.03.022","article-title":"The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study","volume":"44","author":"Barzilay","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.14.2.193_bb0150","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"Am J Med."},{"key":"10.4158\/EP.14.2.193_bb0155","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation."},{"key":"10.4158\/EP.14.2.193_bb0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(92)90201-Q","article-title":"Microalbuminuria and associated cardiovascular risk factors in the community","volume":"93","author":"Winocour","year":"1992","journal-title":"Atherosclerosis."},{"key":"10.4158\/EP.14.2.193_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(95)05631-9","article-title":"Insulin sensitivity in clinically healthy individuals with microalbuminuria","volume":"119","author":"Jensen","year":"1996","journal-title":"Atherosclerosis."},{"key":"10.4158\/EP.14.2.193_bb0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2796.1996.23849000.x","article-title":"Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population","volume":"240","author":"Zavaroni","year":"1996","journal-title":"J Intern Med."},{"key":"10.4158\/EP.14.2.193_bb0180","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s001250050970","article-title":"Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study","volume":"41","author":"Jager","year":"1998","journal-title":"Diabetologia."},{"key":"10.4158\/EP.14.2.193_bb0185","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/diabetes.47.5.793","article-title":"Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study","volume":"47","author":"Mykk\u00e4nen","year":"1998","journal-title":"Diabetes."},{"key":"10.4158\/EP.14.2.193_bb0190","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diacare.28.4.910","article-title":"Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association","volume":"28","author":"De Cosmo","year":"2005","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.14.2.193_bb0195","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.193_bb0200","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cll.2006.06.007","article-title":"Measures of insulin sensitivity","volume":"26","author":"Bloomgarden","year":"2006","journal-title":"Clin Lab Med."},{"key":"10.4158\/EP.14.2.193_bb0205","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"4","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/37736557553237W5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:49Z","timestamp":1761515269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20428800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1530891X20428800"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.2.193","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.2.193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}